These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 32968868)
1. Preparation and Evaluation of Cubosomes/Cubosomal Gels for Ocular Delivery of Beclomethasone Dipropionate for Management of Uveitis. Gaballa SA; El Garhy OH; Moharram H; Abdelkader H Pharm Res; 2020 Sep; 37(10):198. PubMed ID: 32968868 [TBL] [Abstract][Full Text] [Related]
2. Brain Targeting of Duloxetine HCL via Intranasal Delivery of Loaded Cubosomal Gel: In vitro Characterization, ex vivo Permeation, and in vivo Biodistribution Studies. Elsenosy FM; Abdelbary GA; Elshafeey AH; Elsayed I; Fares AR Int J Nanomedicine; 2020; 15():9517-9537. PubMed ID: 33324051 [TBL] [Abstract][Full Text] [Related]
3. Optimization of hyaluronan-enriched cubosomes for bromfenac delivery enhancing corneal permeation: characterization, ex vivo, and in vivo evaluation. Shoman NA; Gebreel RM; El-Nabarawi MA; Attia A Drug Deliv; 2023 Dec; 30(1):2162162. PubMed ID: 36587627 [TBL] [Abstract][Full Text] [Related]
4. Mesoporous Silica Nanoparticles Coated with Carboxymethyl Chitosan for 5-Fluorouracil Ocular Delivery: Characterization, In Vitro and In Vivo Studies. Alhowyan AA; Kalam MA; Iqbal M; Raish M; El-Toni AM; Alkholief M; Almomen AA; Alshamsan A Molecules; 2023 Jan; 28(3):. PubMed ID: 36770926 [TBL] [Abstract][Full Text] [Related]
5. Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: Improving preocular retention and ocular bioavailability. Gan L; Han S; Shen J; Zhu J; Zhu C; Zhang X; Gan Y Int J Pharm; 2010 Aug; 396(1-2):179-87. PubMed ID: 20558263 [TBL] [Abstract][Full Text] [Related]
6. Novel vehicle based on cubosomes for ophthalmic delivery of flurbiprofen with low irritancy and high bioavailability. Han S; Shen JQ; Gan Y; Geng HM; Zhang XX; Zhu CL; Gan L Acta Pharmacol Sin; 2010 Aug; 31(8):990-8. PubMed ID: 20686524 [TBL] [Abstract][Full Text] [Related]
7. Topical Delivery of Erythromycin Through Cubosomes for Acne. Khan S; Jain P; Jain S; Jain R; Bhargava S; Jain A Pharm Nanotechnol; 2018; 6(1):38-47. PubMed ID: 29424323 [TBL] [Abstract][Full Text] [Related]
9. Delineating penetration enhancer-enriched liquid crystalline nanostructures as novel platforms for improved ophthalmic delivery. El-Gendy MA; Mansour M; El-Assal MIA; Ishak RAH; Mortada ND Int J Pharm; 2020 May; 582():119313. PubMed ID: 32283196 [TBL] [Abstract][Full Text] [Related]
10. Poloxamer-based thermoresponsive ketorolac tromethamine in situ gel preparations: Design, characterisation, toxicity and transcorneal permeation studies. M A Fathalla Z; Vangala A; Longman M; Khaled KA; Hussein AK; El-Garhy OH; Alany RG Eur J Pharm Biopharm; 2017 May; 114():119-134. PubMed ID: 28126392 [TBL] [Abstract][Full Text] [Related]
11. Formulation, In-Vitro and Ex-Vivo Evaluation of Tretinoin Loaded Cubosomal Gel for the Treatment of Acne. Sureka S; Gupta G; Agarwal M; Mishra A; K Singh S; P Singh R; Sah SK; de Jesus A Pinto T; Dua K Recent Pat Drug Deliv Formul; 2018; 12(2):121-129. PubMed ID: 29437029 [TBL] [Abstract][Full Text] [Related]
12. Cubogel as potential platform for glaucoma management. Sayed S; Abdel-Moteleb M; Amin MM; Khowessah OM Drug Deliv; 2021 Dec; 28(1):293-305. PubMed ID: 33509004 [TBL] [Abstract][Full Text] [Related]
13. Mucoadhesive chitosan-coated cationic microemulsion of dexamethasone for ocular delivery: in vitro and in vivo evaluation. Kesavan K; Kant S; Singh PN; Pandit JK Curr Eye Res; 2013 Mar; 38(3):342-52. PubMed ID: 23216079 [TBL] [Abstract][Full Text] [Related]
14. Intranasal administration of innovative triamcinolone acetonide encapsulated cubosomal Patil R; Patil AS; Chougule K; Gaude Y; Masareddy RS Drug Dev Ind Pharm; 2024 Jan; 50(1):68-77. PubMed ID: 38148515 [TBL] [Abstract][Full Text] [Related]
15. Novel cubosome based system for ocular delivery of acetazolamide. Teba HE; Khalil IA; El Sorogy HM Drug Deliv; 2021 Dec; 28(1):2177-2186. PubMed ID: 34662264 [TBL] [Abstract][Full Text] [Related]
16. Preclinical assessment of nanostructured liquid crystalline particles for the management of bacterial keratitis: in vivo and pharmacokinetics study. Kaul S; Nagaich U; Verma N Drug Deliv Transl Res; 2022 Jul; 12(7):1719-1737. PubMed ID: 34582029 [TBL] [Abstract][Full Text] [Related]
17. Gel in core carbosomes as novel ophthalmic vehicles with enhanced corneal permeation and residence. Moustafa MA; El-Refaie WM; Elnaggar YSR; Abdallah OY Int J Pharm; 2018 Jul; 546(1-2):166-175. PubMed ID: 29778824 [TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo evaluation of cubosomal nanoparticles as an ocular delivery system for fluconazole in treatment of keratomycosis. Nasr M; Teiama M; Ismail A; Ebada A; Saber S Drug Deliv Transl Res; 2020 Dec; 10(6):1841-1852. PubMed ID: 32779112 [TBL] [Abstract][Full Text] [Related]
20. Comparative studies on glycerol monooleate- and phytantriol-based cubosomes containing oridonin in vitro and in vivo. Shi X; Peng T; Huang Y; Mei L; Gu Y; Huang J; Han K; Li G; Hu C; Pan X; Wu C Pharm Dev Technol; 2017 May; 22(3):322-329. PubMed ID: 26670780 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]